{"title":"Daiwa Brain Health（北海道扇贝油质原）和 Prevagen（Apoaequorin）对认知功能的影响比较：办公室试点研究。","authors":"Fred Pescatore","doi":"","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>Daiwa Brain Health, which contains Hokkaido scallop oil plasmalogen, was compared with Prevagen, the market leader in the category of cognitive function improvement.</p><p><strong>Methods: </strong>Thirty people with subjective cognitive decline or its premorbidities were divided into 2 groups of 15 people each, and each group was given either Daiwa Brain Health or Prevagen for 90 days. The Abbreviated Mental Test Score (AMTS) and Standardized Mini-Mental State Examination (SMMSE) were conducted before treatment and after 90 days of treatment to evaluate cognitive function.</p><p><strong>Results: </strong>Participants who took Daiwa Brain Health showed statistically significant improvement in AMTS and SMMSE scores between baseline and 90 days of treatment, while participants who took Prevagen showed no statistically significant improvement in AMTS or SMMSE scores between baseline and after 90 days of treatment. The AMTS and SMMSE scores indicated higher cognitive function at 90 days after treatment for the participants who took Daiwa Brain Health compared with those who took Prevagen, and those differences were statistically significant.</p><p><strong>Conclusion: </strong>Daiwa Brain Health is more effective than Prevagen at improving cognitive function.</p>","PeriodicalId":1,"journal":{"name":"Accounts of Chemical Research","volume":null,"pages":null},"PeriodicalIF":16.4000,"publicationDate":"2024-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of Daiwa Brain Health (Hokkaido Scallop Oil Plasmalogen) and Prevagen (Apoaequorin) on Cognitive Function: An In-Office Pilot Study.\",\"authors\":\"Fred Pescatore\",\"doi\":\"\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Objective: </strong>Daiwa Brain Health, which contains Hokkaido scallop oil plasmalogen, was compared with Prevagen, the market leader in the category of cognitive function improvement.</p><p><strong>Methods: </strong>Thirty people with subjective cognitive decline or its premorbidities were divided into 2 groups of 15 people each, and each group was given either Daiwa Brain Health or Prevagen for 90 days. The Abbreviated Mental Test Score (AMTS) and Standardized Mini-Mental State Examination (SMMSE) were conducted before treatment and after 90 days of treatment to evaluate cognitive function.</p><p><strong>Results: </strong>Participants who took Daiwa Brain Health showed statistically significant improvement in AMTS and SMMSE scores between baseline and 90 days of treatment, while participants who took Prevagen showed no statistically significant improvement in AMTS or SMMSE scores between baseline and after 90 days of treatment. The AMTS and SMMSE scores indicated higher cognitive function at 90 days after treatment for the participants who took Daiwa Brain Health compared with those who took Prevagen, and those differences were statistically significant.</p><p><strong>Conclusion: </strong>Daiwa Brain Health is more effective than Prevagen at improving cognitive function.</p>\",\"PeriodicalId\":1,\"journal\":{\"name\":\"Accounts of Chemical Research\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":16.4000,\"publicationDate\":\"2024-10-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Accounts of Chemical Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"\",\"RegionNum\":1,\"RegionCategory\":\"化学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"CHEMISTRY, MULTIDISCIPLINARY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Accounts of Chemical Research","FirstCategoryId":"3","ListUrlMain":"","RegionNum":1,"RegionCategory":"化学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"CHEMISTRY, MULTIDISCIPLINARY","Score":null,"Total":0}
Comparison of Daiwa Brain Health (Hokkaido Scallop Oil Plasmalogen) and Prevagen (Apoaequorin) on Cognitive Function: An In-Office Pilot Study.
Objective: Daiwa Brain Health, which contains Hokkaido scallop oil plasmalogen, was compared with Prevagen, the market leader in the category of cognitive function improvement.
Methods: Thirty people with subjective cognitive decline or its premorbidities were divided into 2 groups of 15 people each, and each group was given either Daiwa Brain Health or Prevagen for 90 days. The Abbreviated Mental Test Score (AMTS) and Standardized Mini-Mental State Examination (SMMSE) were conducted before treatment and after 90 days of treatment to evaluate cognitive function.
Results: Participants who took Daiwa Brain Health showed statistically significant improvement in AMTS and SMMSE scores between baseline and 90 days of treatment, while participants who took Prevagen showed no statistically significant improvement in AMTS or SMMSE scores between baseline and after 90 days of treatment. The AMTS and SMMSE scores indicated higher cognitive function at 90 days after treatment for the participants who took Daiwa Brain Health compared with those who took Prevagen, and those differences were statistically significant.
Conclusion: Daiwa Brain Health is more effective than Prevagen at improving cognitive function.
期刊介绍：
Accounts of Chemical Research presents short, concise and critical articles offering easy-to-read overviews of basic research and applications in all areas of chemistry and biochemistry. These short reviews focus on research from the author’s own laboratory and are designed to teach the reader about a research project. In addition, Accounts of Chemical Research publishes commentaries that give an informed opinion on a current research problem. Special Issues online are devoted to a single topic of unusual activity and significance.
Accounts of Chemical Research replaces the traditional article abstract with an article "Conspectus." These entries synopsize the research affording the reader a closer look at the content and significance of an article. Through this provision of a more detailed description of the article contents, the Conspectus enhances the article's discoverability by search engines and the exposure for the research.
分享
京公网安备 11010802042870号
京ICP备2023020795号-1
求助内容：
应助结果提醒方式：
扫码关注我们
